Current Surgical is a Washington, D.C.-based medical technology company pioneering AI-powered autonomous surgery. We are developing a software-enabled surgical platform that empowers doctors to precisely and micro-invasively treat a range of diseases, offering a new approach to cancer treatment and beyond.

Our technology combines real-time imaging with precise energy delivery, utilizing AI-driven algorithms to enhance surgeon precision and confidence during complex procedures. This innovative platform, known as the ‘smart’ needle, is designed to treat cancerous tumors with millimeter-level control, significantly improving outcomes and minimizing human error.

Current Surgical is backed by top-tier venture capital firms including True Ventures, 1517, and Scifounders, and has received grants from the National Science Foundation and the NIH. We are building the foundational platform for the next generation of minimally invasive surgery, with a roadmap targeting solid tumor ablation by 2025, followed by cardiac arrhythmias, chronic pain, hypertension, epilepsy, and other neural interventions – representing multi-billion dollar surgical markets.

Our team comprises experts in surgical robotics, ultrasound, deep learning, and commercializing medical technology, bringing a wealth of experience to the development and deployment of this transformative surgical platform.

Smart Needle | Current Surgical

Product description

Current Surgical Washington, United States (US)

Price: N/A

Current Surgical
Washington, United States (US)